BIOGEN INC. Financing Cash Flow
BIOGEN INC. (BIIB) reported Financing Cash Flow of -$43.80 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-04-29
- BIOGEN INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$43.80M.
- BIOGEN INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$137.00M, a 1834.18% decline year-over-year.
- BIOGEN INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$130.20M.
- BIOGEN INC. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was -$11.70M.
- BIOGEN INC. net cash provided by (used in) financing activities for fiscal 2025 was -$301.90M.
- BIOGEN INC. net cash provided by (used in) financing activities for fiscal 2024 was -$683.50M, a 557.80% decline from fiscal 2023.
- BIOGEN INC. net cash provided by (used in) financing activities for fiscal 2023 was $149.30M.
- BIOGEN INC. net cash provided by (used in) financing activities for fiscal 2022 was -$1.75B.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$43.80M 10-Q · filed 2026-04-29 | -$180.80M derived: sum of 2 quarters · filed 2026-04-29 | -$311.00M derived: sum of 3 quarters · filed 2026-04-29 | -$322.70M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | -$137.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$267.20M derived: sum of 2 quarters · filed 2026-02-06 | -$278.90M derived: sum of 3 quarters · filed 2026-02-06 | -$301.90M 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | -$130.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$141.90M derived: sum of 2 quarters · filed 2025-10-30 | -$164.90M 10-Q · filed 2025-10-30 | -$157.00M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | -$11.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$34.70M 10-Q · filed 2025-07-31 | -$26.80M derived: sum of 3 quarters · filed 2026-04-29 | -$33.40M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | -$23.00M 10-Q · filed 2026-04-29 | -$15.10M derived: sum of 2 quarters · filed 2026-04-29 | -$21.70M derived: sum of 3 quarters · filed 2026-04-29 | -$266.90M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $1.30M derived: sum of 2 quarters · filed 2026-02-06 | -$243.90M derived: sum of 3 quarters · filed 2026-02-06 | -$683.50M 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | -$6.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$251.80M derived: sum of 2 quarters · filed 2025-10-30 | -$691.40M 10-Q · filed 2025-10-30 | -$1.34B derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | -$245.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$684.80M 10-Q · filed 2025-07-31 | -$1.33B derived: sum of 3 quarters · filed 2026-02-06 | -$482.30M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | -$439.60M 10-Q · filed 2025-05-01 | -$1.09B derived: sum of 2 quarters · filed 2026-02-06 | -$237.10M derived: sum of 3 quarters · filed 2026-02-06 | -$246.90M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | -$646.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $202.50M derived: sum of 2 quarters · filed 2026-02-06 | $192.70M derived: sum of 3 quarters · filed 2026-02-06 | $149.30M 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | $848.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $838.80M derived: sum of 2 quarters · filed 2024-10-30 | $795.40M 10-Q · filed 2024-10-30 | $788.00M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | -$9.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$53.20M 10-Q · filed 2024-08-01 | -$60.60M derived: sum of 3 quarters · filed 2025-02-12 | -$1.31B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | -$43.40M 10-Q · filed 2024-04-24 | -$50.80M derived: sum of 2 quarters · filed 2025-02-12 | -$1.30B derived: sum of 3 quarters · filed 2025-02-12 | -$1.77B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | -$7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$1.26B derived: sum of 2 quarters · filed 2025-02-12 | -$1.73B derived: sum of 3 quarters · filed 2025-02-12 | -$1.75B 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | -$1.25B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$1.72B derived: sum of 2 quarters · filed 2023-11-08 | -$1.74B 10-Q · filed 2023-11-08 | -$1.73B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | -$471.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | -$488.00M 10-Q · filed 2023-07-25 | -$478.20M derived: sum of 3 quarters · filed 2024-02-14 | -$1.22B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | -$16.50M 10-Q · filed 2023-04-25 | -$6.70M derived: sum of 2 quarters · filed 2024-02-14 | -$753.20M derived: sum of 3 quarters · filed 2024-02-14 | -$1.32B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | $9.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$736.70M derived: sum of 2 quarters · filed 2024-02-14 | -$1.30B derived: sum of 3 quarters · filed 2024-02-14 | -$2.09B 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | -$746.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | -$1.31B derived: sum of 2 quarters · filed 2022-10-25 | -$2.10B 10-Q · filed 2022-10-25 | -$2.50B derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | -$564.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | -$1.35B 10-Q · filed 2022-07-20 | -$1.75B derived: sum of 3 quarters · filed 2023-02-15 | -$3.06B derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | -$785.00M 10-Q · filed 2022-05-03 | -$1.19B derived: sum of 2 quarters · filed 2023-02-15 | -$2.50B derived: sum of 3 quarters · filed 2023-02-15 | -$3.81B derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | -$401.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$1.71B derived: sum of 2 quarters · filed 2023-02-15 | -$3.03B derived: sum of 3 quarters · filed 2023-02-15 | -$5.27B 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | -$1.31B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | -$2.63B derived: sum of 2 quarters · filed 2021-10-20 | -$4.87B 10-Q · filed 2021-10-20 | -$6.99B derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | -$1.31B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | -$3.56B 10-Q · filed 2021-07-22 | -$5.68B derived: sum of 3 quarters · filed 2022-02-03 | -$6.36B derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | -$2.25B 10-Q · filed 2021-04-22 | -$4.36B derived: sum of 2 quarters · filed 2022-02-03 | -$5.05B derived: sum of 3 quarters · filed 2022-02-03 | -$7.43B derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | -$2.12B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | -$2.81B derived: sum of 2 quarters · filed 2022-02-03 | -$5.18B derived: sum of 3 quarters · filed 2022-02-03 | -$5.86B 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | -$689.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-21 | -$3.06B derived: sum of 2 quarters · filed 2020-10-21 | -$3.74B 10-Q · filed 2020-10-21 | -$5.18B derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-06-30 | -$2.38B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22 | -$3.06B 10-Q · filed 2020-07-22 | -$4.49B derived: sum of 3 quarters · filed 2021-02-03 | -$4.47B derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | -$679.30M 10-Q · filed 2020-04-23 | -$2.12B derived: sum of 2 quarters · filed 2021-02-03 | -$2.09B derived: sum of 3 quarters · filed 2021-02-03 | -$4.88B derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | -$1.44B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | -$1.41B derived: sum of 2 quarters · filed 2021-02-03 | -$4.20B derived: sum of 3 quarters · filed 2021-02-03 | -$4.47B 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | $25.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | -$2.77B derived: sum of 2 quarters · filed 2019-10-22 | -$3.04B 10-Q · filed 2019-10-22 | -$3.74B derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | -$2.79B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$3.06B 10-Q · filed 2019-07-24 | -$3.77B derived: sum of 3 quarters · filed 2020-02-06 | -$3.79B derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | -$268.60M 10-Q · filed 2019-04-24 | -$976.70M derived: sum of 2 quarters · filed 2020-02-06 | -$996.20M derived: sum of 3 quarters · filed 2020-02-06 | -$1.75B derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | -$708.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | -$727.60M derived: sum of 2 quarters · filed 2020-02-06 | -$1.48B derived: sum of 3 quarters · filed 2020-02-06 | -$2.38B 10-K · filed 2020-02-06 | ||||
| 2017-09-30 | -$19.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | -$770.50M derived: sum of 2 quarters · filed 2018-10-23 | -$1.67B 10-Q · filed 2018-10-23 | -$2.40B derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-06-30 | -$751.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-24 | -$1.65B 10-Q · filed 2018-07-24 | -$2.38B derived: sum of 3 quarters · filed 2019-02-06 | -$2.68B derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-03-31 | -$901.40M 10-Q · filed 2018-04-24 | -$1.63B derived: sum of 2 quarters · filed 2019-02-06 | -$1.93B derived: sum of 3 quarters · filed 2019-02-06 | -$1.95B derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | -$726.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$1.03B derived: sum of 2 quarters · filed 2019-02-06 | -$1.05B derived: sum of 3 quarters · filed 2019-02-06 | -$1.05B 10-K · filed 2019-02-06 | -$987.80M 10-K · filed 2017-02-02 | |||
| 2016-09-30 | -$305.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | -$321.10M derived: sum of 2 quarters · filed 2017-10-24 | -$326.10M 10-Q · filed 2017-10-24 | -$266.60M 10-Q · filed 2016-10-26 | -$2.53B derived: sum of 4 quarters · filed 2018-02-01 | |||
| 2016-06-30 | -$15.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | -$20.80M 10-Q · filed 2017-07-25 | $34.00M 10-Q · filed 2016-07-21 | -$2.22B derived: sum of 3 quarters · filed 2018-02-01 | $685.10M derived: sum of 4 quarters · filed 2018-02-01 | |||
| 2016-03-31 | -$5.00M 10-Q · filed 2017-04-25 | $47.40M 10-Q · filed 2016-04-21 | -$2.21B derived: sum of 2 quarters · filed 2018-02-01 | $700.90M derived: sum of 3 quarters · filed 2018-02-01 | $697.30M derived: sum of 4 quarters · filed 2018-02-01 | |||
| 2015-12-31 | -$2.20B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $705.90M derived: sum of 2 quarters · filed 2018-02-01 | $702.30M derived: sum of 3 quarters · filed 2018-02-01 | $783.10M 10-K · filed 2018-02-01 | $986.40M 10-K · filed 2016-02-03 | |||
| 2015-09-30 | $2.91B derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | $2.90B derived: sum of 2 quarters · filed 2016-10-26 | $2.98B 10-Q · filed 2016-10-26 | $2.98B 10-Q · filed 2015-10-21 | $2.47B derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-06-30 | -$3.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-21 | $77.20M 10-Q · filed 2016-07-21 | $77.22M 10-Q · filed 2015-07-24 | -$436.09M derived: sum of 3 quarters · filed 2017-02-02 | -$471.21M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-03-31 | $80.80M 10-Q · filed 2016-04-21 | $80.76M 10-Q · filed 2015-04-24 | -$432.49M derived: sum of 2 quarters · filed 2017-02-02 | -$467.62M derived: sum of 3 quarters · filed 2017-02-02 | -$789.98M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | -$513.29M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | -$548.41M derived: sum of 2 quarters · filed 2017-02-02 | -$870.77M derived: sum of 3 quarters · filed 2017-02-02 | -$755.90M 10-K · filed 2017-02-02 | -$755.87M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | -$35.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | -$357.48M derived: sum of 2 quarters · filed 2015-10-21 | -$242.61M 10-Q · filed 2015-10-21 | -$231.40M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | -$322.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-24 | -$207.49M 10-Q · filed 2015-07-24 | -$196.28M derived: sum of 3 quarters · filed 2016-02-03 | -$514.80M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | $114.88M 10-Q · filed 2015-04-24 | $126.08M derived: sum of 2 quarters · filed 2016-02-03 | -$192.44M derived: sum of 3 quarters · filed 2016-02-03 | -$363.20M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | $11.21M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | -$307.31M derived: sum of 2 quarters · filed 2016-02-03 | -$478.08M derived: sum of 3 quarters · filed 2016-02-03 | -$716.50M 10-K · filed 2016-02-03 | -$716.53M 10-K · filed 2014-02-06 | |||
| 2013-09-30 | -$318.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-22 | -$489.29M derived: sum of 2 quarters · filed 2014-10-22 | -$727.71M 10-Q · filed 2014-10-22 | -$743.23M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | -$170.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-23 | -$409.19M 10-Q · filed 2014-07-23 | -$424.71M derived: sum of 3 quarters · filed 2015-02-04 | -$452.96M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | -$238.42M 10-Q · filed 2014-04-23 | -$253.95M derived: sum of 2 quarters · filed 2015-02-04 | -$282.20M derived: sum of 3 quarters · filed 2015-02-04 | -$699.64M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | -$15.52M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | -$43.77M derived: sum of 2 quarters · filed 2015-02-04 | -$461.21M derived: sum of 3 quarters · filed 2015-02-04 | -$877.48M 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | -$28.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | -$445.69M derived: sum of 2 quarters · filed 2013-10-28 | -$861.95M 10-Q · filed 2013-10-28 | -$1.00B derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | -$417.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | -$833.70M 10-Q · filed 2013-07-25 | -$976.51M derived: sum of 3 quarters · filed 2014-02-06 | -$1.08B derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | -$416.26M 10-Q · filed 2013-04-25 | -$559.07M derived: sum of 2 quarters · filed 2014-02-06 | -$658.20M derived: sum of 3 quarters · filed 2014-02-06 | -$636.29M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | -$142.81M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | -$241.94M derived: sum of 2 quarters · filed 2014-02-06 | -$220.03M derived: sum of 3 quarters · filed 2014-02-06 | -$319.86M 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | -$99.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-25 | -$77.22M derived: sum of 2 quarters · filed 2012-10-25 | -$177.05M 10-Q · filed 2012-10-25 | $48.87M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-06-30 | $21.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-24 | -$77.92M 10-Q · filed 2012-07-24 | $148.00M derived: sum of 3 quarters · filed 2013-02-05 | -$313.26M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-03-31 | -$99.83M 10-Q · filed 2012-05-01 | $126.09M derived: sum of 2 quarters · filed 2013-02-05 | -$335.17M derived: sum of 3 quarters · filed 2013-02-05 | -$1.36B derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2010-12-31 | $225.93M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | -$235.33M derived: sum of 2 quarters · filed 2013-02-05 | -$1.26B derived: sum of 3 quarters · filed 2013-02-05 | -$1.78B 10-K · filed 2013-02-05 | ||||
| 2010-09-30 | -$461.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | -$1.49B derived: sum of 2 quarters · filed 2011-10-28 | -$2.01B 10-Q · filed 2011-10-28 | -$2.68B derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-06-30 | -$1.03B derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-26 | -$1.55B 10-Q · filed 2011-07-26 | -$2.22B derived: sum of 3 quarters · filed 2012-02-03 | -$2.21B derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-03-31 | -$523.46M 10-Q · filed 2011-04-21 | -$1.19B derived: sum of 2 quarters · filed 2012-02-03 | -$1.18B derived: sum of 3 quarters · filed 2012-02-03 | -$1.18B derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2009-12-31 | -$666.76M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | -$660.37M derived: sum of 2 quarters · filed 2012-02-03 | -$657.22M derived: sum of 3 quarters · filed 2012-02-03 | -$724.15M 10-K · filed 2012-02-03 | ||||
| 2009-09-30 | $6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | $9.53M derived: sum of 2 quarters · filed 2010-10-26 | -$57.39M 10-Q · filed 2010-10-26 | -$54.56M 10-Q · filed 2009-10-21 | -$389.19M derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2009-06-30 | $3.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-20 | -$63.78M 10-Q · filed 2010-07-20 | -$395.57M derived: sum of 3 quarters · filed 2011-02-04 | -$260.74M derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2009-03-31 | -$66.93M 10-Q · filed 2010-04-20 | -$398.72M derived: sum of 2 quarters · filed 2011-02-04 | -$263.89M derived: sum of 3 quarters · filed 2011-02-04 | |||||
| 2008-12-31 | -$331.79M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | -$196.96M derived: sum of 2 quarters · filed 2011-02-04 | -$1.23B 10-K · filed 2011-02-04 | |||||
| 2008-09-30 | $134.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-21 | -$902.83M 10-Q · filed 2009-10-21 | ||||||
| 2008-06-30 | -$1.04B 10-Q · filed 2009-07-17 | |||||||
| 2007-12-31 | -$733.34M 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |